Karyopharm Therapeutics I... (KPTI)
7.24
-0.71 (-8.93%)
At close: Mar 03, 2025, 3:59 PM
7.61
5.11%
After-hours: Mar 03, 2025, 04:01 PM EST
Karyopharm Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -76.42M | -143.1M | -165.29M | -124.09M | -196.27M | -199.59M | -178.41M | -128.98M | -109.58M | -118.18M | -75.78M | -33.95M | -15.89M | -10.31M |
| Depreciation & Amortization | -2.16M | 530K | 621K | 789K | 972K | 974K | 735K | 713K | 717K | 634K | 323K | 144K | 122K | 83K |
| Stock-Based Compensation | 18.43M | 21.71M | 35.4M | 29.78M | 24.41M | 15.29M | 17.27M | 20.41M | 22.28M | 17.06M | 14.24M | 3.79M | 653K | 24K |
| Other Working Capital | n/a | 9.76M | -15.96M | -9.26M | 5.54M | -1.8M | 1.21M | 32.05M | 42K | 6.42M | 5.22M | -1.02M | -330K | 524K |
| Other Non-Cash Items | -67.33M | -3.28M | -294K | 8.13M | 8.4M | 7.19M | 1.42M | 1.19M | 1.2M | 685K | 52K | 88K | 257K | n/a |
| Deferred Income Tax | n/a | n/a | n/a | 1.45M | 904K | -1.38M | 29K | n/a | n/a | 1.78M | n/a | n/a | n/a | n/a |
| Change in Working Capital | n/a | 31.41M | -19.99M | -23.19M | 1.36M | -13.31M | -169K | 32.96M | 987K | 4M | 9.71M | -360K | -396K | 1.66M |
| Operating Cash Flow | -127.49M | -92.72M | -149.55M | -107.12M | -160.23M | -190.82M | -159.12M | -73.72M | -84.39M | -94.03M | -51.45M | -30.29M | -15.51M | -8.55M |
| Capital Expenditures | -142K | n/a | -118K | -5.71M | -145K | -206K | -2.36M | -62K | -70K | -1.42M | -2.83M | -57K | -121K | -376K |
| Acquisitions | n/a | n/a | 104.26M | 5.5M | 53.54M | -78.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -58.82M | -159.15M | -226.02M | -45.23M | -274.58M | -178.49M | -242.81M | -98.37M | -134.7M | -305.19M | -63.8M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 154.44M | 167.09M | 121.88M | 192.78M | 221.04M | 257.14M | 137.51M | 115.54M | 159.37M | 215.87M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | -104.26M | -5.5M | -53.54M | 78.66M | -105.3M | 17.17M | 24.66M | -82K | -400K | n/a | n/a | n/a |
| Investing Cash Flow | 95.47M | 7.94M | -104.26M | 141.84M | -53.69M | 78.45M | -107.66M | 17.11M | 24.59M | -90.82M | -67.03M | -57K | -121K | -376K |
| Debt Repayment | 83.3M | n/a | n/a | n/a | n/a | n/a | 166.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | 111M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -41.65M | 1.12M | 3.98M | 63.74M | 10.31M | 78.11M | 3.52M | 858K | 591K | 616K | 284K | 72.78M | 9.5M | 11.98M |
| Financial Cash Flow | 41.65M | 1.12M | 193.74M | 73.65M | 172.08M | 124.31M | 316.11M | 75.74M | 51.16M | 92.7M | 113.12M | 185.93M | 9.51M | 11.99M |
| Net Cash Flow | 9.62M | -83.69M | -60.56M | 108.32M | -41.57M | 11.95M | 49.25M | 19.33M | -8.7M | -92.25M | -5.37M | 155.58M | -6.12M | 3.07M |
| Free Cash Flow | -127.63M | -92.72M | -149.67M | -112.83M | -160.38M | -191.03M | -161.48M | -73.78M | -84.46M | -95.44M | -54.28M | -30.35M | -15.63M | -8.93M |